Skip to main content
SpringerLink
Log in

Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

A combined supplement of magnesium oxide (300 mg/day) and pyridoxine·HCl (10 mg/day) was given p.o. to 16 recurrent calcium oxalate (CaOx) stone formers, and its therapeutic efficacy was biochemically evaluated by measuring various parameters of blood (Na, K, Mg, urea, creatinine, calcium, phosphate, uric acid, alanine transaminase, aspartate transaminase and alkaline phosphatase) and urine (volume, pH, creatinine, Na, K, Mg, uric acid, calcium, phosphate, oxalate and citrate) at 0, 30, 60, 90 and 120 days of treatment. Serum Mg significantly (P<0.01) increased after 30 days of treatment and remained constant thereafter while other blood parameters were unaltered. Combined treatment led to a significant increase in the urinary excretion of Mg and citrate over pretreatment values while oxalate excretion showed a gradual and significant decline during the therapy. The results confirmed the efficacy of MgO-pyridoxine supplementation in terms of changes in urinary excretion of lithogenic and inhibitory components, leading to a significant (P<0.01) decrease in CaOx risk index from 0.09±0.04 at 0 day to 0.05±0.02 after 120 days of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahlstrand C, Tiselius HG (1984) Biochemical effects in patients with calcium oxalate stone disease during combined treatment with bendroflumethiazide and MgO. Br J Urol 56:125–130

    Google Scholar 

  2. Backman U, Danielson BG, Fellstrom B, Johansson G, Ljunghall S, Wikstrom B (1979) Biochemical and clinical effects of prophylactic treatment of renal calcium stones with magnesium hydroxide. Scand J Urol Nephrol [Suppl]51

  3. Berg W, Bother C, Pirlich W, Janitzky V (1986) Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 12:274–282

    Google Scholar 

  4. Danpure CJ (1991) Molecular and clinical heterogeneity in primary hyperoxaluria type I. Am J Kidney Dis 17:366–369

    Google Scholar 

  5. Fetner CD, Barilla DE, Townsend J, Pak CYC (1978) Effects of MgO on crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. J Urol 120:399–408

    Google Scholar 

  6. Fiske CH, Subbarow Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66:375–400

    Google Scholar 

  7. Gershoff SN (1964) Vitamin B6 and oxalate metabolism. Vitam Horm 22:581–589

    Google Scholar 

  8. Gibbs DA, Watts RWE (1970) The action of pyridoxine in primary hyperoxaluria. Clin Sci 38:277–286

    Google Scholar 

  9. Harrison AR, Kasidas GP, Rose GA (1981) Hyperoxaluria and recurrent stome formation apparently cured by short courses of pyridoxine. Br Med J 282:2097–2098

    Google Scholar 

  10. Henry RJ (1967) Determination of uric acid by reaction with alkaline phosphotungstate. In: Henry RJ (ed) Clinical chemistry: principles and techniques. Harper and Row, New York, pp 278–283

    Google Scholar 

  11. Hodgkinson A (1974) Relations between oxalic acid, calcium, magnesium and creatinine excretion in normal men and male patients with calcium oxalate kidney stones. Clin Sci Mol Med 46:357–367

    Google Scholar 

  12. Hodgkinson A, Williams A (1972) An improved colorimetric procedure for urine oxalate. Clin Chim Acta 36:127–132

    Google Scholar 

  13. Lindberg J, Harvey J, Pak CYC (1990) Effect of magnesium citrate and MgO on the crystallization of calcium salts in urine: changes produced by food — Mg interaction. J Urol 143:248–251

    Google Scholar 

  14. Melnick I, Lands RR, Hoffman AA, Burch JP (1971) Magnesium therapy for recurring calcium oxalate urinary calculi. J Urol 105:119–123

    Google Scholar 

  15. Menon M, Koul H (1992) Clinical review: calcium oxalate urolithiasis. J Clin Endocrinol Metab 74:703–707

    Google Scholar 

  16. Moore CA, Bunce GE (1964) Reduction in frequency of renal calculus formation by oral Mg administration. Invest Urol 2:7–13

    Google Scholar 

  17. Murthy MSR, Farooqui S, Talwar HS, Thind SK, Nath R, Rajendran L, Bapna BC (1982) Effect of pyridoxine supplementation on recurrent stone formers. Int J Clin Pharmacol Ther Toxicol 20:434–437

    Google Scholar 

  18. Murthy MSR, Talwar HS, Thind SK, Nath R (1982) Vitamin B6 deficiency as related to oxalate synthesising enzymes in growing rats. Ann Nutr Metab 26:201–208

    Google Scholar 

  19. Natelson S (1963) Microtechniques of clinical chemistry, 2nd edn. Thomas, Springfield

    Google Scholar 

  20. Ogawa Y, Yamaguchi K, Morozumi M (1990) Effects of magnesium salts in preventing oxalate urolithiasis in rats. J Urol 144:385–389

    Google Scholar 

  21. Prien EL, Gershoff SF (1974) MgO: pyridoxine therapy for recurrent calcium oxalate calculi. J Urol 112:509–512

    Google Scholar 

  22. Rattan V, Thind SK, Jethi RK, Sidhu H, Nath R (1993) Oxalate metabolism in magnesium-deficient rats. Magnes Res 6:125–131

    Google Scholar 

  23. Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin BEC (1976) Saturation-inhibition index as a measure of risk of calcium oxlate stone formation in the urinary tract. N Engl J Med 294:249–252

    Google Scholar 

  24. Sakhaee K, Nicar M, Hill K, Pak CYC (1983) Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistry and crystallization of stone forming salts. Kidney Int 24:348–352

    Google Scholar 

  25. Smith LH (1990) Idiopathic calcium oxalate urolithiasis Endocrinol Metab Clin North Am 19:937–947

    Google Scholar 

  26. Takasaki E (1972) The magnesium-calcium ratio in the concentrated urines of patients with calcium oxalate calculi. Invest Urol 10:147–150

    Google Scholar 

  27. Takasaki E (1975) Urinary magnesium and oxalic acid ecretion in patients with recurrent oxalate urolithiasis. Invest Urol 12:251–259

    Google Scholar 

  28. Tiselius HG (1982) An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 122:409–418

    Google Scholar 

  29. Tiselius HG, Ahlstrand C, Larsson L (1980) Urine composition in patients with urolithiasis during treatment with MgO. Urol Res 8:197–200

    Google Scholar 

  30. Trinder P (1960) Calcium determination by precipitation. In: Wootton IDP (ed) Microanalysis in medical biochemistry, 4th edn. London, Churchill, p 176

    Google Scholar 

  31. Uribari J, Man S, Carroll JH (1989) The first kidney stone. Ann Intern Med 111:1006–1009

    Google Scholar 

  32. White JCD, Davies DJ (1963) The determination of citric acid in milk and milk sera. J Dairy Res 30:171–189

    Google Scholar 

  33. Will EJ, Bijovet OLM (1979) Primary hyperoxaluria, clinical and biochemical response to high dose pyridoxine therapy. Metab Clin Exp 28:542–547

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Postgraduate Institute of Medical Education and Research, 160012, Chandigarh, India

    V. Rattan, H. Sidhu, S. K. Thind & R. Nath

  2. Department of Urology, Postgraduate Institute of Medical Education and Research, 160012, Chandigarh, India

    S. Vaidyanathan

Authors
  1. V. Rattan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Sidhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Vaidyanathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. K. Thind
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Nath
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rattan, V., Sidhu, H., Vaidyanathan, S. et al. Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers. Urol. Res. 22, 161–165 (1994). https://doi.org/10.1007/BF00571844

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00571844

Key words

Search

Navigation